Semaglutide is one of the most widely studied incretin mimetics in modern metabolic pharmacology laboratories. As a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist analogue, it serves as a reference compound in receptor pharmacology studies, analytical chemistry method development, and comparative structureโactivity research on peptide therapeutics. This article examines its molecular architecture, the design features laboratories […]
